Supriya Nagarajan

Senior Research Associate I at ReCode Therapeutics

Supriya Nagarajan has a diverse range of work experience. Supriya is currently working as a Senior Research Associate I at ReCode Therapeutics since April 2023. Prior to that, they worked at CRISPR Therapeutics as a Senior Research Associate from April 2022 to April 2023.

Supriya also worked at Laronde, where they held various roles including Senior Research Associate from March 2022 to April 2022, Research Associate II from September 2021 to March 2022, and Research Associate from September 2019 to September 2021.

In addition, Supriya has experience as a Research Associate co-op at Silicon Therapeutics from January 2019 to June 2019, and as a Clinical drug development Co-op at Biogen from July 2018 to December 2018.

Supriya started their professional journey as a Research Assistant at Northeastern University from January 2018 to May 2018.

Supriya also gained valuable experience as an Intern at Nanavati Super Speciality Hospital in 2016, where they assisted pharmacists in medication dispensing, clinical pharmacologists in prescription auditing, and contributed to medication error reporting.

Furthermore, they worked as an Intern at Indo-German Alkaloids Laboratories in 2016, where they conducted quality control tests on formulated products, performed physical parameter tests on tablets and capsules, checked packaging labels, and familiarized herself with the Microbiology and Manufacturing departments.

Supriya Nagarajan completed a Bachelor's degree in Pharmacy at SVKM's Narsee Monjee Institute of Management Studies (NMIMS) from 2013 to 2017. From 2017 to 2019, they attended Northeastern University, but no specific degree or field of study is provided for this period. Additionally, they hold a certification as a Registered Pharmacist from the Pharmacist council of India, although the month and year of obtaining this certification are not specified.

Links

Previous companies

Laronde logo
CRISPR Therapeutics logo

Timeline

  • Senior Research Associate I

    April, 2023 - present